During the past decade, Saint Francis Hospital conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 137 clinical trials were completed, i.e. on average, 94.5% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 76 clinical trials were completed. i.e. 172.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Francis Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 107 trials, followed by "SWOG Cancer Research Network" with 43 trials sponsored, "Alliance for Clinical Trials in Oncology" with 30 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "Seagen Inc." with 11 trials sponsored. Other sponsors include 75 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Francis Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 119 trials as a collaborator, "NRG Oncology" with 30 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 7 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Saint Francis Hospital" are "Breast Cancer" (18 trials), "Lung Cancer" (10 trials), "Lymphoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials) and "Multiple Myeloma" (9 trials). Many other conditions were trialed in "Saint Francis Hospital" in a lesser frequency.

Most popular intervention types in "Saint Francis Hospital" are "Drug" (222 trials), "Other" (148 trials), "Biological" (98 trials), "Procedure" (66 trials) and "Radiation" (44 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (76 trials), "Quality-of-Life Assessment" (51 trials), "Questionnaire Administration" (37 trials), "Paclitaxel" (33 trials) and "Carboplatin" (27 trials). Other intervention names were less common.

The vast majority of trials in "Saint Francis Hospital" are 218 trials for "All" genders, 56 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Francis Hospital". undefined are not yet recruiting, 39 are recruiting, 106 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 108 completed trials in Saint Francis Hospital, 6 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Francis Hospital, 12 "Phase 1" clinical trials were conducted, 110 "Phase 2" clinical trials and 154 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".

Saint Francis Hospital has several departments that took part in Clinical trials: "Saint Francis Cancer Center" - 179 trials, "Bon Secours Liver Institute of Richmond" - 33 trials, "Bon Secours Cancer Institute at Reynolds Crossing" - 32 trials, "Liver Institute of Virginia" - 30 trials, "Bon Secours DePaul Medical Center" - 27 trials, "Upstate Cardiology" - 13 trials, "Cardiovascular Associates of Virginia" - 6 trials, "Bon Secours Cancer Care at St. Mary's Hospital" - 5 trials, "Tuckahoe Orthopedics" - 4 trials, "Bon Secours Heart & Vascular Institute" - 3 trials, "Upstate Oncology Associates" - 3 trials, "Bon Secours Cancer Institute" - 3 trials, "Richmond Cardiology Associates" - 2 trials, "Neurology Associates, Inc. (St. Mary's Hospital)" - 2 trials